Abide Therapeutics, Inc.;The Scripps Research Institute
发明人:
申请号：
EP17197501.4
公开号：
EP3326627A1
申请日:
2013.01.07
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
This disclosure provides compounds and compositions which may be modulators of MAGL and/or ABHD6 and their use as medicinal agents, processes for their preparation, and pharmaceutical compositions that include disclosed compounds as at least one active agent. The disclosure also provides for method of treating a patient in need thereof, where the patient is suffering from indications such as pain, solid tumor cancer and/or obesity comprising administering a disclosed compound or composition.
